These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29708531)
1. A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay. Wang Y; Chen D; Chen M; Ji K; Ma D; Zhou L J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708531 [TBL] [Abstract][Full Text] [Related]
2. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization. Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479 [TBL] [Abstract][Full Text] [Related]
3. VHL-deficient vasculogenesis in hemangioblastoma. Gläsker S; Smith J; Raffeld M; Li J; Oldfield EH; Vortmeyer AO Exp Mol Pathol; 2014 Apr; 96(2):162-7. PubMed ID: 24394472 [TBL] [Abstract][Full Text] [Related]
4. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. Stratmann R; Krieg M; Haas R; Plate KH J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235 [TBL] [Abstract][Full Text] [Related]
5. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390 [TBL] [Abstract][Full Text] [Related]
6. Von hippel-lindau disease: a genetic and clinical review. Haddad NM; Cavallerano JD; Silva PS Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system]. Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758 [TBL] [Abstract][Full Text] [Related]
8. Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Takayanagi S; Mukasa A; Tanaka S; Nomura M; Omata M; Yanagisawa S; Yamamoto S; Ichimura K; Nakatomi H; Ueki K; Aburatani H; Saito N Neuro Oncol; 2017 Sep; 19(9):1228-1236. PubMed ID: 28379443 [TBL] [Abstract][Full Text] [Related]
9. [Genetics and angiogenesis: the example of von Hippel-Lindau disease]. Richard S; Ladroue C; Gad S; Giraud S; Gardie B; Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002 [TBL] [Abstract][Full Text] [Related]
10. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900 [TBL] [Abstract][Full Text] [Related]
11. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease. Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589 [TBL] [Abstract][Full Text] [Related]
12. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene. Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice. Wang Y; Yang J; Du G; Ma D; Zhou L Mol Carcinog; 2017 Oct; 56(10):2342-2351. PubMed ID: 28574654 [TBL] [Abstract][Full Text] [Related]
15. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701 [TBL] [Abstract][Full Text] [Related]
16. Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report. Taylor DG; Ilyas A; Mehta GU; Chen CJ; Schiff D; Oldfield EH; Asthagiri AR J Clin Neurosci; 2018 Apr; 50():154-156. PubMed ID: 29396065 [TBL] [Abstract][Full Text] [Related]
17. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease. Cuesta AM; Albiñana V; Gallardo-Vara E; Recio-Poveda L; de Rojas-P I; de Las Heras KVG; Aguirre DT; Botella LM Sci Rep; 2019 Jul; 9(1):10062. PubMed ID: 31296894 [TBL] [Abstract][Full Text] [Related]
18. [Hemangioblastoma and von Hippel-Lindau Disease]. Takayanagi S; Takami H; Tanaka S; Saito N No Shinkei Geka; 2022 Jan; 50(1):101-110. PubMed ID: 35169090 [TBL] [Abstract][Full Text] [Related]
19. Von Hippel-Lindau disease: a single gene, several hereditary tumors. Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383 [TBL] [Abstract][Full Text] [Related]
20. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]